This is a special way doctors treat cancer. They use electricity to help medicines get into cancer cells better. It's a type of cancer treatment.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Electrochemotherapy (ECT) is a local cancer treatment that combines a chemotherapy drug with short, strong electric pulses aimed at a tumor. The pulses briefly open tiny pores in the membranes of the cells they reach, a process called electroporation. While those pores are open, the drug can flow into the tumor cells in much larger amounts than it normally would, and the cells die. The drug most often used is bleomycin, an older chemotherapy medicine that on its own enters cells poorly. Electroporation makes it far more potent inside the treated area, so a modest dose can have a strong effect where the pulses are applied while leaving the rest of the body largely untouched. This is also the main limitation: ECT treats only the lesions it is applied to. It does not reach cancer elsewhere in the body.
ECT is used mainly for cancer that has spread to the skin or just beneath it, most often from melanoma or breast cancer, when surgery is not practical. Skin metastases can bleed, ulcerate, smell, hurt or affect appearance, and ECT is used to shrink them and ease those problems. In the United Kingdom, national guidance supports it as a palliative treatment for skin metastases, meaning the goal is symptom control and quality of life rather than cure. It is often considered when radiation or other treatments have already been used or are unsuitable. It is sometimes used for primary skin cancers such as basal cell carcinoma or squamous cell carcinoma, typically when a tumor is in a hard-to-operate place or a person cannot have surgery. Because surgery and other established treatments cure most of these cancers, ECT is reserved for selected cases. Specialist centers are also studying it for deeper tumors, such as in the liver, spine or digestive tract, and for some vascular malformations in children; these uses are still early.
Treatment is usually a single session, often done as an outpatient. Depending on the number, size and location of the lesions, it is done under general anesthesia or local anesthesia with or without sedation. The chemotherapy is given first, either through a vein (useful when there are many or larger lesions) or injected directly into each tumor (for a few small ones). A few minutes later, the clinician places an electrode on or into the tumor and delivers a brief burst of pulses. Plate electrodes rest on the skin surface, while needle electrodes are inserted into thicker lesions. Larger tumors need several applications to cover the whole area. The pulses make nearby muscles twitch or contract sharply, which is one reason anesthesia is used. The procedure should be done by a clinician trained in the technique, with patients selected by a cancer team that can weigh other options.
After treatment, the area is usually sore, red and swollen for a few days. Over the following weeks, treated tumors typically darken, form a crust or scab, and may leave a shallow open wound that drains fluid for a while. This breakdown is part of how the treatment works rather than a sign that it failed, and in one trial all such wounds had healed within about four months. Wound care and pain relief are part of the aftercare. The response is usually judged at a follow-up visit several weeks to a couple of months later. Some tumors disappear completely, others shrink, and a few do not respond. Small tumors respond best. Because ECT can be repeated, lesions that persist or new ones that appear can often be treated again, within the lifetime limits on how much of the chemotherapy drug a person can receive. Treated skin may be left with scarring or lighter or darker patches.
ECT has been studied for about 30 years, mostly in skin tumors. Across thousands of patients, roughly 8 in 10 treated skin tumors shrink, and pooled studies of skin metastases found that about half disappear completely. Small tumors are more than twice as likely to clear completely as large ones. For squamous cell skin cancer, about two thirds of treated tumors cleared in pooled studies. Studies also report less bleeding, oozing and pain in people whose tumors respond, although these quality-of-life measures were often informal. The limits matter. Nearly all of this evidence comes from case series and registries rather than randomized trials, and there are essentially no trials comparing ECT with radiation, a common alternative for skin lesions. Results also tend to come from experienced centers. ECT controls the treated lesions only, so it is not expected to change the course of cancer elsewhere in the body. Its use with immunotherapy for melanoma and in deeper organs is being studied, but those results are preliminary.
The most common effects are pain at the treated site, crusting and ulceration while the tumor breaks down, extra wound discharge for a time, and lasting scars or skin color changes. Contact your care team promptly if you notice spreading redness, warmth or fever around the wound, or bleeding that does not stop. Bleomycin can, uncommonly, inflame and scar the lungs. The risk is higher in older adults and rises with the total amount received over a lifetime, so the team tracks the cumulative dose, especially if you have had bleomycin before or have lung disease. Tell the team about a new cough or shortness of breath. Bleomycin can also harm a developing baby, so pregnancy needs to be discussed beforehand. Tumors in the mouth or throat need special planning, because swelling after treatment can narrow the airway and some people have needed a breathing tube. If you have trouble breathing after treatment in the mouth or throat, call 911. Lesions near major nerves or blood vessels carry a risk of nerve injury or bleeding. ECT is also not widely available, and access can depend on where you live and whether a specialist center offers it.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Electrochemotherapy, what's helped you, or ask the community a question.